Technical Analysis for RPHM - Reneo Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 7.78 -2.87% -0.23
RPHM closed down 2.87 percent on Friday, May 14, 2021, on 1.53 times normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical RPHM trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Older End-of-Day Signals for RPHM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible Inside Day about 11 hours ago
Possible Pocket Pivot about 12 hours ago
Rose Above Lower Bollinger Band about 15 hours ago
3x Volume Pace about 15 hours ago
2x Volume Pace about 15 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. The company was incorporated in 2014 and is headquartered in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Industry Clinical Research Clinical Trial Stage Pharmaceutical Transcription Factors Carboxylic Acids Intracellular Receptors

Is RPHM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.1799
52 Week Low 7.63
Average Volume 96,309
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 12.98
10-Day Moving Average 12.65
Average True Range 1.12
ADX 23.14
+DI 7.13
-DI 45.29
Chandelier Exit (Long, 3 ATRs ) 11.58
Chandelier Exit (Short, 3 ATRs ) 11.00
Upper Bollinger Band 16.84
Lower Bollinger Band 9.13
Percent B (%b) -0.17
BandWidth 59.44
MACD Line -0.92
MACD Signal Line -0.06
MACD Histogram -0.8568
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.73
Resistance 3 (R3) 9.90 9.41 9.41
Resistance 2 (R2) 9.41 8.92 9.33 9.30
Resistance 1 (R1) 8.60 8.61 8.36 8.43 9.19
Pivot Point 8.11 8.11 7.99 8.03 8.11
Support 1 (S1) 7.30 7.62 7.06 7.13 6.37
Support 2 (S2) 6.81 7.31 6.73 6.26
Support 3 (S3) 6.00 6.81 6.16
Support 4 (S4) 5.83